Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
about
T cell response to Hu-D peptides in patients with anti-Hu syndromeScavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic CellsSwitching and emergence of CTL epitopes in HIV-1 infectionThe antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.Sequence- and interactome-based prediction of viral protein hotspots targeting host proteins: a case study for HIV Nef.Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef.Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized.The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes.Apoptotic peptides derived from HIV-1 Nef induce lymphocyte depletion in miceTwo human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines.Characterization of Nef-CXCR4 interactions important for apoptosis induction.Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.Automatic sequence design of major histocompatibility complex class I binding peptides impairing CD8+ T cell recognition.
P2860
Q24654675-0301DBB1-FF34-478C-830F-5D679763CEBEQ27485559-978021B9-A7B8-40CA-8D02-23499A7F4487Q27684028-63D882F0-93E3-4BE0-BA19-D307D1E300F3Q33904028-99FAA094-75B8-41CF-8796-B96792F7D91AQ33906726-01ACFB9C-1296-442D-98D7-1F933931BAD2Q33954592-2C45B95D-3EC7-4EAC-9297-0CAC3807D97BQ34348731-A718AA46-7108-4A3A-9F05-C6AE1B94DF5AQ35146742-10966D86-5298-48B8-A1C6-C0DE9601454CQ35157414-D99D6B65-E553-4611-BE86-11C5B969293FQ35784867-3497FD88-9F5F-4F2C-BAD8-F88E81834E67Q35821221-ADC09612-3212-4057-9A96-0BEC66474781Q36473740-F8F4652E-AAC9-442C-AEB5-ED766A6B7F56Q36799875-57384A4B-E7DF-4A13-AB13-3353A1A57B9FQ37066897-20429333-AFBA-4EAF-BCB0-B0D6F6A3FAAAQ39162494-121A673A-69EB-4E8F-A894-7ACB7C2AA10DQ39699425-010CE5C2-EBB5-4CC8-B2C9-DAB085687370Q40054175-D816C656-4B11-46F8-A2B4-93EF7A14D3FAQ40161550-206A3A19-B6C3-44AC-B9A3-4C5825CA18DFQ40756949-CDC19689-ECEC-4A54-A949-FC7EF5535866Q47615055-27610E93-BF2E-491A-8D3F-9F8F8572AB54
P2860
Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Characteristics of HIV-1 Nef r ...... ity to proteasome degradation.
@en
type
label
Characteristics of HIV-1 Nef r ...... ity to proteasome degradation.
@en
prefLabel
Characteristics of HIV-1 Nef r ...... ity to proteasome degradation.
@en
P2093
P1476
Characteristics of HIV-1 Nef r ...... ity to proteasome degradation.
@en
P2093
Guillet JG
P304
P356
10.4049/JIMMUNOL.166.10.6164
P407
P577
2001-05-01T00:00:00Z